Balaxi Pharmaceuticals Ltd
BALAXI
Company Profile
Business description
Balaxi Pharmaceuticals Ltd is an Indian branded IPR-based pharmaceutical company focusing on frontier markets, with a vast and growing portfolio of prescription and OTC drugs, across multiple therapeutic segments. Geographically it earns key revenue from Guatemala.
Contact
Phase-III, Road No: 81, Jubilee Hills
Plot No.409, H,No: 8-2-293
MAPS Towers, 3rd Floor
HyderabadTG500 096
INDT: +91 4023555300
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
46
Stocks News & Analysis
stocks
The most overvalued commodity sector right now
With recent movements in commodity prices, we identify shares to avoid at current prices.
stocks
Arcadium a steal but how much difference will it make to Rio Tinto
Rio have made a counter-cyclical move to buy some of the world's lowest-cost lithium assets. Our mining analyst Jon Mills says the firm is still all about iron ore for now.
stocks
Are we in the last days of ASX dividend dominance?
Some of the largest ASX listed companies are potential dividend traps. What should income investors do?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,573.90 | 24.70 | -0.29% |
| CAC 40 | 7,521.97 | 80.09 | -1.05% |
| DAX 40 | 19,486.19 | 22.10 | -0.11% |
| Dow JONES (US) | 42,740.42 | 324.80 | -0.75% |
| FTSE 100 | 8,249.28 | 43.38 | -0.52% |
| HKSE | 20,243.30 | 75.49 | -0.37% |
| NASDAQ | 18,315.59 | 187.10 | -1.01% |
| Nikkei 225 | 39,128.76 | 781.79 | -1.96% |
| NZX 50 Index | 12,701.17 | 139.60 | -1.09% |
| S&P 500 | 5,815.26 | 44.59 | -0.76% |
| S&P/ASX 200 | 8,299.40 | 19.00 | -0.23% |
| SSE Composite Index | 3,190.94 | 10.35 | -0.32% |